Article at Genomeweb: ”Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Test”
17 October 2024
Johan Hartman is a guest at the Johnson & Johnson
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Johan Hartman is a guest at the Johnson & Johnson
Advances in breast cancer research are providing entirely new opportunities
Johan Hartman is a guest at the Johnson & Johnson
Stratipath is thrilled to announce a collaboration with Roche, the
In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated
Stratipath is proud to announce that globally recognized breast oncologist,
Capio St Göran’s Hospital is one of the largest breast
Stratipath is thrilled to announce a collaboration with Roche, the
Johan Hartman is a guest at the Johnson & Johnson
Swelife conducted an interview with our Chief Medical Officer and